Is Pola Orbis Holdings profitable in 2026?

Yes. Pola Orbis reported FY2025 net sales of ¥170.29bn (flat YoY) and operating profit of ¥15.69bn (+13.6% YoY) as of December 31, 2025, with net profit of ¥9.47bn. However, FY2026 guidance issued February 16, 2026 calls for net profit to decline 5.0% to ¥9.0bn.

Is Pola Orbis doing layoffs?

Yes. On February 13, 2026 the company announced a Next Career Special Support Plan targeting about 160 POLA Inc. employees for early retirement, booking a roughly ¥1.4bn extraordinary loss in FY2026. Group headcount had already fallen from 4,128 (Dec 2022) to 3,898 (Dec 2025).

Could AI replace Pola Orbis's Beauty Directors?

AI skin-diagnostic tools from Perfect Corp, Haut.AI and Orbo already analyze 15 to 40+ skin parameters via smartphone camera, and rivals Kosé and Shiseido reportedly shipped AI diagnostics in 2025. Pola Orbis has no confirmed public AI-diagnostic product as of mid-2026, exposing its in-person consultation model to substitution.

Who is Pola Orbis Holdings' biggest competitor?

Shiseido is Japan's largest cosmetics maker with ¥990.6bn FY2024 revenue and about 13% Japan skincare share, while Kosé posted ¥318.5bn FY2025 net sales and around 12% share. Both outspend Pola Orbis and reportedly moved faster on AI skin diagnostics in 2025.

Who owns Pola Orbis Holdings?

Pola Orbis Holdings Inc. (ticker 4927) is a publicly listed company on the Tokyo Stock Exchange Prime Market with no parent company. Major reported shareholders as of February 6, 2026 include the Government Pension Investment Fund of Japan at 3.51%; market cap was about ¥290bn as of July 25, 2026.

Is the POLA brand declining or growing in 2026?

POLA, the flagship brand, is declining: Q1 FY2026 sales fell 6.3% year over year as of March 31, 2026, amid China and duty-free weakness. By contrast, sister brand ORBIS grew, with operating income up 23.5% YoY in the same quarter.

Consumer brands · Japan

Pola Orbis Holdings Inc.

polaorbis.co.jp ↗

Japanese holding company behind door-to-door brand Pola and skincare brand Orbis.

Losing its protection

Assessed 25 July 2026 · Evidence as of 25 July 2026

The structural protection is eroding.

On the recordSince 25 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: Q2 FY2026 earnings release, showing whether POLA brand decline has bottomed

The call

Pola Orbis stays profitable but is shrinking its flagship brand and staff while rivals roll out AI diagnostics and Chinese sales slip.

Pola Orbis sells premium skincare and cosmetics mainly through its own shops and salespeople called Beauty Directors who give personal advice and build long-term customer relationships. The company is struggling because its main POLA brand has been shrinking, bigger competitors like Shiseido and Kosé are stealing customers with their own products, and new AI tools that can analyze skin and suggest treatments are making the in-person salesperson less essential, which is Pola's whole business model. The big question is whether Pola can launch its own AI skin-analysis tool fast enough to keep up with its rivals, or if it will keep shrinking and lose even more business.

Why

AI pressure: Kosé and Shiseido's AI skin diagnostic tools (built on vendors like Perfect Corp, Haut.AI). Rivals now offer AI skin scans that replace the in-person consult Pola uses to justify its premium sales visits. Could AI do the core job? Only partly.

Bigger players: Shiseido and Kosé, Japan's larger cosmetics groups, plus Chinese Guochao and K-beauty brands. Bigger rivals and Chinese upstarts are pulling share from Pola's flagship brand as its sales keep falling. Could a giant copy it? Yes, easily.

What protects it. Roughly 2,400 shops and thousands of Beauty Directors hold personal customer relationships and data rivals lack.

What would change this call

Pola Orbis Q2/Q3 FY2026 earnings (Aug and Nov 2026) show whether POLA brand sales keep declining past -6%. Continued decline confirms the flagship brand is losing ground to rivals, not stabilizing.
Pola Orbis announces (or fails to announce) an AI-diagnostic or digital-consultation product within 12-18 months. Absence would show the Beauty Director model is being bypassed while Kose and Shiseido already shipped AI tools.
Any further subsidiary dissolution or restructuring announcement beyond Orbis Beijing and the POLA early-retirement plan. Additional retreats would confirm managed contraction rather than a turnaround.

Key numbers

POLA brand sales fell 6.3% in Q1 FY2026 (2026-03-31)
ORBIS operating income rose 23.5% in Q1 FY2026 (2026-03-31)
FY2025 net sales flat at ¥170.29bn (2025-12-31)

Named risks

POLA flagship brand multi-year sales decline, -6.3% YoY in Q1 FY2026. Severity: high
No confirmed in-house AI skin-diagnostic product while Kosé and Shiseido reportedly shipped theirs in 2025. Severity: high
China market retreat: Orbis Beijing subsidiary dissolved May 2025 amid stagnating demand and e-commerce competition. Severity: medium
Restructuring costs recurring: ~¥1.4bn early-retirement charge booked FY2026, headcount falling annually since 2022. Severity: medium
FY2026 guidance implies further net profit decline (-5.0%) despite modest sales growth. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Shiseido	losing to	Shiseido ~13% Japan skincare share vs Pola Orbis mid-tier position, ¥990.6bn FY2024 revenue
Kosé	losing to	Kosé reportedly shipped AI skin diagnostics in 2025; Pola Orbis has no confirmed equivalent
Chinese Guochao and K-beauty brands	losing to	Erosion of POLA and Jurlique China share amid duty-free and e-commerce competition, 2025 filings
L'Oreal	losing to	L'Oreal outspends on R&D at >€1.2bn/year versus Pola Orbis's smaller domestic R&D budget
Fancl (Kirin) and Mandom	contesting	Peers consolidated via Kirin acquisition (Dec 2024) and MBO delisting (Apr 2026) amid sector pressure

Questions people ask

Is Pola Orbis Holdings profitable in 2026?: Yes. Pola Orbis reported FY2025 net sales of ¥170.29bn (flat YoY) and operating profit of ¥15.69bn (+13.6% YoY) as of December 31, 2025, with net profit of ¥9.47bn. However, FY2026 guidance issued February 16, 2026 calls for net profit to decline 5.0% to ¥9.0bn.
Is Pola Orbis doing layoffs?: Yes. On February 13, 2026 the company announced a Next Career Special Support Plan targeting about 160 POLA Inc. employees for early retirement, booking a roughly ¥1.4bn extraordinary loss in FY2026. Group headcount had already fallen from 4,128 (Dec 2022) to 3,898 (Dec 2025).
Could AI replace Pola Orbis's Beauty Directors?: AI skin-diagnostic tools from Perfect Corp, Haut.AI and Orbo already analyze 15 to 40+ skin parameters via smartphone camera, and rivals Kosé and Shiseido reportedly shipped AI diagnostics in 2025. Pola Orbis has no confirmed public AI-diagnostic product as of mid-2026, exposing its in-person consultation model to substitution.
Who is Pola Orbis Holdings' biggest competitor?: Shiseido is Japan's largest cosmetics maker with ¥990.6bn FY2024 revenue and about 13% Japan skincare share, while Kosé posted ¥318.5bn FY2025 net sales and around 12% share. Both outspend Pola Orbis and reportedly moved faster on AI skin diagnostics in 2025.
Who owns Pola Orbis Holdings?: Pola Orbis Holdings Inc. (ticker 4927) is a publicly listed company on the Tokyo Stock Exchange Prime Market with no parent company. Major reported shareholders as of February 6, 2026 include the Government Pension Investment Fund of Japan at 3.51%; market cap was about ¥290bn as of July 25, 2026.
Is the POLA brand declining or growing in 2026?: POLA, the flagship brand, is declining: Q1 FY2026 sales fell 6.3% year over year as of March 31, 2026, amid China and duty-free weakness. By contrast, sister brand ORBIS grew, with operating income up 23.5% YoY in the same quarter.

Timeline

2026-05-11Q1 FY2026 results: sales +1.0% YoY to ¥41.31bn, but POLA brand sales down 6.3%
2026-04-14Results of Next Career Special Support Plan (early retirement) disclosed
2026-02-16FY2026 guidance issued: sales +1.6% to ¥173.0bn, net profit -5.0% to ¥9.0bn
2026-02-13Board approves early retirement plan for ~160 POLA Inc. employees, ~¥1.4bn cost
2025-12-31FY2025 closes: net sales ¥170.29bn flat YoY, operating profit ¥15.69bn +13.6%
2025-06-19Shareholder benefit program revamped, effective December 2026
2025-05-26Board resolves to dissolve Orbis Beijing Inc., mainland China ORBIS subsidiary since 2008
2024-03-31POLA Aoyama flagship building opens, boosting real estate segment revenue
2006-09-29Pola Orbis Holdings established as holding company structure

Head to head

Pola Orbis Holdings Inc. vs Shiseido

Revision history

25 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

PVH VF Kering